Research Topic

Recent Advancements in Neoadjuvant Chemotherapy for Specific Breast Cancer Subtypes

About this Research Topic

Most patients with locally advanced breast cancer undergo pre-surgery treatment known as neoadjuvant chemotherapy (NAC) to reduce the tumor’s size and improve surgical outcomes, cosmetic results, and chances of conservative management, as well as to control tumor progression and observe tumor sensitivity (or resistance) to the chosen treatment regimen. Studies have documented better survival outcomes in patients achieving a complete pathological remission than patients who have residual or progressive disease at the time of definitive surgery. The mechanisms of primary resistance and strategies to overcome those are a matter of intense research.

In this Research Topic, we will focus on studies that tackle the most recent advances in diagnosing and treating breast cancer using neoadjuvant systemic therapy. The focus is on new biomarkers and targeted therapies, including immunotherapy. Apart from tumor molecular characteristics, we will also cover the patient’s genetics and metabolism.
This collection will include Original Research papers and Review Articles.

Manuscripts should focus on:
- The clinical effects of neoadjuvant therapy on different breast cancer intrinsic subtypes; new treatment options
- Post-neoadjuvant treatment strategies for patients with residual or progressive disease
- Molecular characterization of primary and residual tumors
- Neoadjuvant chemotherapy in patients with underlying genetic abnormalities or metabolic dysfunction
- New neoadjuvant treatment strategies
- Advances in neoadjuvant clinical trial’s design


Keywords: Breast cancer, Neoadjuvant Chemotherapy, Luminal subtypes, HER-2, biomarkers, Post-neoadjuvant, Primary resistance


Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

Most patients with locally advanced breast cancer undergo pre-surgery treatment known as neoadjuvant chemotherapy (NAC) to reduce the tumor’s size and improve surgical outcomes, cosmetic results, and chances of conservative management, as well as to control tumor progression and observe tumor sensitivity (or resistance) to the chosen treatment regimen. Studies have documented better survival outcomes in patients achieving a complete pathological remission than patients who have residual or progressive disease at the time of definitive surgery. The mechanisms of primary resistance and strategies to overcome those are a matter of intense research.

In this Research Topic, we will focus on studies that tackle the most recent advances in diagnosing and treating breast cancer using neoadjuvant systemic therapy. The focus is on new biomarkers and targeted therapies, including immunotherapy. Apart from tumor molecular characteristics, we will also cover the patient’s genetics and metabolism.
This collection will include Original Research papers and Review Articles.

Manuscripts should focus on:
- The clinical effects of neoadjuvant therapy on different breast cancer intrinsic subtypes; new treatment options
- Post-neoadjuvant treatment strategies for patients with residual or progressive disease
- Molecular characterization of primary and residual tumors
- Neoadjuvant chemotherapy in patients with underlying genetic abnormalities or metabolic dysfunction
- New neoadjuvant treatment strategies
- Advances in neoadjuvant clinical trial’s design


Keywords: Breast cancer, Neoadjuvant Chemotherapy, Luminal subtypes, HER-2, biomarkers, Post-neoadjuvant, Primary resistance


Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

About Frontiers Research Topics

With their unique mixes of varied contributions from Original Research to Review Articles, Research Topics unify the most influential researchers, the latest key findings and historical advances in a hot research area! Find out more on how to host your own Frontiers Research Topic or contribute to one as an author.

Topic Editors

Loading..

Submission Deadlines

26 December 2020 Abstract
25 April 2021 Manuscript

Participating Journals

Manuscripts can be submitted to this Research Topic via the following journals:

Loading..

Topic Editors

Loading..

Submission Deadlines

26 December 2020 Abstract
25 April 2021 Manuscript

Participating Journals

Manuscripts can be submitted to this Research Topic via the following journals:

Loading..
Loading..

total views article views article downloads topic views

}
 
Top countries
Top referring sites
Loading..